Navigation Links
Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
Date:10/30/2007

n and gathering any evidence of anti-tumour activity.

THIRD QUARTER RESULTS OF OPERATIONS

(for the three months ended September 30, 2007 and 2006)

Net loss for the three month period ending September 30, 2007 was $3,763,901 compared to $3,425,169 for the three month period ending September 30, 2006.

Research and Development Expenses ("R&D")

2007 2006

$ $

-------------------------------------------------------------------------

Manufacturing and related process

development expenses 879,937 1,259,716

Clinical trial expenses 1,278,175 688,435

Pre-clinical trial and research

collaboration expenses 293,785 301,165

Other R&D expenses 438,747 456,430

-------------------------------------------------------------------------

Research and development expenses 2,890,644 2,705,746

-------------------------------------------------------------------------

-------------------------------------------------------------------------

For the third quarter of 2007, R&D increased to $2,890,644 compared to $2,705,746 for the third quarter of 2006. The increase in R&D was due to the following:

Manufacturing & Related Process Development ("M&P")

2007 2006

$ $

-------------------------------------------------------------------------

Product manufacturing expenses 610,842 896,776

Technology transfer expenses - 184,761

Process development expenses 269
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email: